Ankylosing Spondylitis Market to Reach $8.68 Billion by 2029, Growing at a CAGR of 8.2%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Ankylosing Spondylitis Industry In 2025?

The market size for ankylosing spondylitis has experienced substantial growth in recent years. Projections indicate that it will expand from $5.9 billion in 2024 to $6.34 billion in 2025, maintaining a compound annual growth rate (CAGR) of 7.5%. This historical growth can be ascribed to elements such as the discovery of hla-b27, the evolution of biologic treatments, various pain management approaches, enhanced patient advocacy and awareness, as well as the application of NSAIDS and disease modifying drugs.

The ankylosing spondylitis market is anticipated to show significant expansion in the upcoming years, with its size forecast to reach $8.68 billion by 2029, achieving a compound annual growth rate (CAGR) of 8.2%. This growth during the projection period stems from elements such as the personalized medicine approach, advancements in novel biologics, initiatives for early intervention and screening, effective lifestyle and diet management, and the integration of telemedicine and remote monitoring. Prominent trends expected in the forecast period involve the wider availability of biosimilars, the introduction of targeted pain therapies, a heightened emphasis on patient-reported outcomes (PROs), the establishment of community support programs, and the ongoing exploration into regenerative medicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp

What Are The Key Drivers Of Growth In The Ankylosing Spondylitis Market?

The projected rise in the senior demographic is anticipated to stimulate the expansion of the ankylosing spondylitis market moving forward. The geriatric population refers to an increase in the proportion of elderly individuals due to shifts in the age structure of a population. This demographic change has led to a greater number and percentage of people over the age of 60. Treatments and medications for ankylosing spondylitis assist in improving mobility and managing discomfort for the elderly population affected by this condition. For instance, in January 2023, data from the United Nations Department of Economic and Social Affairs (UN DESA), a US-based department of the UN Secretariat, revealed that the global population of individuals aged 65 and older is expected to more than double, growing from 761 million in 2021 to 1.6 billion by 2050. Consequently, the expanding geriatric population is a significant factor driving the growth of the ankylosing spondylitis market.

How Is The Ankylosing Spondylitis Market Classified Into Different Segments?

The ankylosing spondylitismarket covered in this report is segmented –

1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biological Therapies; Steroids; Physical Therapies; Surgery

2) By Molecule: Biologics; Biosimilar; Small Molecules

3) By Route Of Administration: Parenteral; Oral; Other Routes

4) By Application: Juveniles; Adults

5) By End User: Hospitals; Clinics; Research Laboratories; Other End Users

Subsegments:

1) By Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Over-The-Counter NSAIDs; Prescription NSAIDs

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs; Targeted DMARDs

3) By Biological Therapies: TNF Inhibitors; IL-17 Inhibitors

4) By Steroids: Oral Steroids; Injectable Steroids

5) By Physical Therapies: Physiotherapy; Exercise Programs

6) By Surgery: Joint Replacement Surgery; Spinal Surgery

What Trends Are Redefining The Ankylosing Spondylitis Market Dynamics?

Progress in therapeutic alternatives represents a prominent trend gaining traction within the ankylosing spondylitis market. Companies operating in the ankylosing spondylitis sector are actively advancing new treatment options to secure their market position. For instance, in April 2022, AbbVie Inc., a US-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved RINVOQ for the management of adults with active ankylosing spondylitis (AS). This development introduces a novel oral treatment choice for patients who have not responded to TNF blockers, exhibiting notable improvements in disease indicators like back pain and physical function. Its proven rapid efficacy and safety profile from clinical trials position it as a valuable stride in controlling this chronic inflammatory disorder, thereby expanding the array of therapeutic selections available to patients.

Who Are The Top Performing Companies In The Ankylosing Spondylitis Market In Recent Years?

Major companies operating in the ankylosing spondylitis market include Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Cedars-Sinai, Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., UCSF Health, Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report

What Regional Growth Trends Are Shaping The Ankylosing Spondylitis Market Outlook?

North America was the largest region in the ankylosing spondylitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Ankylosing Spondylitis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11962&type=smp

Browse Through More Reports Similar to the Global Ankylosing Spondylitis Market 2025, By The Business Research Company

Personal Care Shower And Bath Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/personal-care-shower-and-bath-global-market-report

Luxury Hair Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/luxury-hair-care-products-global-market-report

Natural Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-skin-care-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795